as 05-20-2024 4:00pm EST
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Founded: | 1979 | Country: | United States |
Employees: | N/A | City: | DUBLIN |
Market Cap: | 24.2B | IPO Year: | N/A |
Target Price: | $107.14 | AVG Volume (30 days): | 2.2M |
Analyst Decision: | Buy | Number of Analysts: | 14 |
Dividend Yield: | 2.06% | Dividend Payout Frequency: | Quarterly |
EPS: | 2.27 | EPS Growth: | 32.75 |
52 Week Low/High: | $80.90 - $116.04 | Next Earning Date: | 05-02-2024 |
Revenue: | $220,572,000,000 | Revenue Growth: | 11.03% |
Revenue Growth (this year): | 11.81% | Revenue Growth (next year): | 8.47% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
WEITZMAN DEBORAH | CAH | CEO, Pharmaceutical Segment | Nov 27 '23 | Sell | $106.31 | 36,642 | $3,895,411.02 | 35,202 | SEC Form 4 |
CAH Breaking Stock News: Dive into CAH Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
MT Newswires
3 days ago
MT Newswires
5 days ago
Argus Research
5 days ago
Argus Research
5 days ago
Simply Wall St.
6 days ago
Zacks
7 days ago
Morningstar Research
12 days ago